Correlation Between Inozyme Pharma and Avidity Biosciences
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Avidity Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Avidity Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Avidity Biosciences, you can compare the effects of market volatilities on Inozyme Pharma and Avidity Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Avidity Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Avidity Biosciences.
Diversification Opportunities for Inozyme Pharma and Avidity Biosciences
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Inozyme and Avidity is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Avidity Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avidity Biosciences and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Avidity Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avidity Biosciences has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Avidity Biosciences go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Avidity Biosciences
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Avidity Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Inozyme Pharma is 1.32 times less risky than Avidity Biosciences. The stock trades about -0.6 of its potential returns per unit of risk. The Avidity Biosciences is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 4,457 in Avidity Biosciences on August 30, 2024 and sell it today you would lose (124.00) from holding Avidity Biosciences or give up 2.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Inozyme Pharma vs. Avidity Biosciences
Performance |
| Timeline |
| Inozyme Pharma |
| Avidity Biosciences |
Inozyme Pharma and Avidity Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Avidity Biosciences
The main advantage of trading using opposite Inozyme Pharma and Avidity Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Avidity Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avidity Biosciences will offset losses from the drop in Avidity Biosciences' long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Avidity Biosciences vs. Revolution Medicines | Avidity Biosciences vs. Black Diamond Therapeutics | Avidity Biosciences vs. Passage Bio | Avidity Biosciences vs. Akero Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |